SCHEMBL279502

SCHEMBL279502

CC(C)(C)OC(=O)N1C(=O)C(=Cc2cc(Cl)ccc2F)c2ccc(Cl)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.37
CYP3A5 P20815 2/20 0.37
APP P05067 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRA6 Q16445 1/20 0.34
USP30 Q70CQ3 1/20 0.34
BCHE P06276 1/20 0.33
AMY1A P0DUB6 2/20 0.32
MAPT P10636 1/20 0.32
SNCA P37840 1/20 0.32
STS P08842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275084 1.00 CYP3A4 (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL275083 1.00 CYP3A4 (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL275036 0.96 AMY1A (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL279181 0.96 AMY1A (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL275035 0.96 AMY1A (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL13929332 0.90 CNR1 (0.37) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL13929386 0.89 CNR1 (0.36) APPMEN1KMT2ACNR1CNR2
SCHEMBL275576 0.89 CYP3A4 (0.35) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL13929360 0.88 MEN1 (0.34) CYP3A4CYP3A5APPMEN1KMT2A
SCHEMBL278932 0.87 FAAH (0.35) CYP3A4CYP3A5APPMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT CYP3A4 185/4885CYP3A5 116/4885APP 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.